Provocation After Nurse-Directed Assessment (PANDA) Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe University of Hong Kong
About this trial
The study aims to evaluate the effectiveness and safety of a collaborative nurse-allergist approach in penicillin allergy delabeling services. It also seeks to assess the impact on patients' quality of life and compare resource utilization and cost-effectiveness between the nurse-allergist collaborative approach and the traditional allergist-led approach.
Eligibility criteria
Qualifiers
Receiving inpatient or outpatient treatment at a participating hospital during the study period;
Possessing a documented penicillin allergy label;
Underwent penicillin allergy evaluation by the nurse-allergist collaborative approach or the traditional allergist-led approach
Demographic and clinical data required for the study available.
Disqualifiers
Patients unable to provide a complete medication history or history of penicillin allergy;
Patients with only emergency or short-term treatment records;
Patients who have taken steroids, antihistamines, or similar medications within the last 3 days.
Trial design
Treatments tested in this trial
- Nurse-led penicillin allergy delabelling service
- Allergist-led penicillin allergy delabelling service
Treatment groups
440 Participants
are divided into 2 treatment groupsLocations
4Prince of Wales Hospital999077, Hong Kong Hong Kong
Princess Margaret Hospital999077, Hong Kong Hong Kong
Queen Elizabeth Hospital999077, Hong Kong Hong Kong
Queen Mary Hospital999077, Hong Kong Hong Kong
Sponsors and collaborators
The University of Hong Kong
Lead sponsor
Source ClinicalTrials.gov